The number of embryos available for transfer predicts successful pregnancy outcome in women over 39 years with normal ovarian hormonal reserve testing

Journal of Assisted Reproduction and Genetics

Volumn 18, Issue 10, 2001, Pages 551-556

  Opsahl, M S ^a   Blauer, K L ^a   Black, S H ^a   Lincoln, S R ^a   Thorsell, L ^a   Sherins, R J ^a  

^a GENETICS AND IVF INSTITUTE   (United States)

Author keywords

Age; FSH; In vitro fertilization; Ovarian reserve; Pregnancy outcome

Indexed keywords

FOLLITROPIN;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE INFERTILITY; OVARY CYCLE; OVARY FUNCTION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; OVARY; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0034763501     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011906024170     Document Type: Article

References (15)

1. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome
2. A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population
3. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age
4. Perimenopausal patterns of gonadotrophins, immunoreactive inhibin, oestradiol and progesterone
5. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age
6. Achieving multiple-order embryo transfer identifies women over 40 years of age with improved in vitro fertilization outcome
7. The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years
8. A comparison of 13 different immunometric assay kits for gonadotropins: Implications for clinical investigation
9. Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotrophin-stimulated cycles for in-vitro fertilization
10. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome
11. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization
12. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels
13. Reproductive aging: Accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women
14. Variability of day 3 follicle-stimulating hormone levels in eumenorrheic women
15. Infertile women of advanced reproductive age. Variability of day 3 FSH and E2 levels